Chronic News and Research

RSS

New book gives hope to women and families who are in difficult stages of anorexia treatment

Women and families struggling with an eating disorder or another addiction should never lose sight of the need to sustain the spirit, according to a new book by Jena Morrow, an author in recovery after more than 20 years with anorexia nervosa. Morrow, a behavioral health specialist at Timberline Knolls Residential Treatment Center, details a battle with anorexia that begins in early childhood in Hollow: An Unpolished Tale, recently released by Moody Publishers.

17 Jun 2010

VBL presents positive preclinical data on VB-201 for rheumatoid arthritis at EULAR

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating that VB-201 possesses anti-inflammatory properties and effectively reduced the symptoms of arthritis in experimental models.

17 Jun 2010

HGS, GSK announce full presentation of BLISS-76 Phase 3 BENLYSTA trial results for SLE at EULAR 2010

Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced the full presentation of results from BLISS-76, one of two pivotal Phase 3 trials of BENLYSTA® (belimumab) in seropositive patients with systemic lupus erythematosus (SLE). The results will be presented today in Rome at the 2010 Congress of the European League Against Rheumatism (EULAR).

17 Jun 2010

Deuterium depletion symposium focusses on oncotherapy, anticancer, diabetes, anti-aging research

1st International Symposium on Deuterium Depletion was held on 13-14 May 2010 in Budapest, Hungary. The conference programme focused on the advances in the research and clinical application of deuterium depletion, its present and future role in anticancer research and oncotherapy, diabetes research and anti-aging.

17 Jun 2010

HHS Secretary announces series of new investments to strengthen primary care workforce

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced a series of new investments worth $250 million to increase the number of health care providers and strengthen the primary care workforce. The new investments were made possible by the Affordable Care Act. Sebelius was joined for the announcement by U.S. Representative Lois Capps, Health Resources and Services Administration Administrator Dr. Mary Wakefield, and HHS Assistant Secretary for Health Dr. Howard K. Koh.

17 Jun 2010

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Cytomedix, Inc., a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that positive results from a prospective study evaluating the AutoloGel™ System to treat advanced, chronic wounds was published in the June 2010 issue of Ostomy Wound Management in a peer reviewed article entitled, "Chronic Wounds Treated With a Physiologically Relevant Concentration of Platelet-rich Plasma (PRP) Gel: A Prospective Case Series."

17 Jun 2010

Hospital waiting time reduced nationally: Report

According to the latest report by the Australian Institute of Health and Welfare (AIHW) hospital admissions have risen significantly up to 16 percent from 2004 to 2009. Admissions in 2008 and 2009 amounted to a whopping 8 million and the report author George Bodilsen felt that multiple factors are responsible for this growing pressure on the nation’s hospitals. “The increase in hospital activity is a reflection of the increasing population, the ageing population, and perhaps the increase in chronic diseases in the population as we age,” he said.

17 Jun 2010

Wednesday's OpEds: Berwick nomination; Health reform costs and benefits; Medicaid and COBRA in jobs bill

As its real costs become clearer, Obama's program is looking even more expensive for employers, seniors, and taxpayers (Rick Santorum, 6/16).

17 Jun 2010

Relypsa commences enrollment for RLY5016 Phase 2 study in heart failure patients with chronic kidney disease

Relypsa, Inc., today announced the initiation of patient enrollment in a Phase 2, open-label titration clinical study of the company's lead drug candidate, RLY5016, in heart failure patients with chronic kidney disease. RLY5016 is a novel non-absorbed oral potassium binder intended to prevent and treat hyperkalemia, a serious condition characterized by elevated serum potassium levels.

16 Jun 2010

Nuon Therapeutics NU1618 phase 2a study in hyperuricemia meets primary endpoint

Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that a phase 2a study of NU1618, the company's lead program, met its primary endpoint of reduction in serum uric acid (sUA) levels in patients with hyperuricemia.

16 Jun 2010

Dutch researcher investigates causes and consequences of insomnia

The brains of older adults with chronic sleep problems look different from those of adults who have enjoyed enough sleep. Yet the older adults function well despite their lack of sleep. They switch to a continuous form of mild stress, as a result of which they sometimes even perform better than contemporaries who enjoy a good night's sleep says Dutch researcher Ellemarije Altena.

16 Jun 2010

CSMG, CSHA awarded Elite status

Cedars-Sinai Medical Group and Cedars-Sinai Health Associates have been awarded Elite status, the highest possible designation for quality care recognized by the California Association of Physician Groups, a professional organization comprised of the state's leading managed care groups. Both organizations are ranked among the top 25 physician organizations in the state in 2010.

16 Jun 2010

Interventions are needed to make people exercise after cardiac event

Researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University found that one year after 248 individuals completed a 12-week cardiac rehabilitation program following a heart attack, bypass surgery or angioplasty, only 37% exercised three times a week to keep their hearts healthy.

16 Jun 2010

Newly published research examines association between CKD and CYP24

Cytochroma today announced the publication of new data from studies in a preclinical model indicating that chronic kidney disease is associated with markedly increased expression of the vitamin D catabolic enzyme, CYP24, which contributes to vitamin D insufficiency and resistance to vitamin D therapy. Parallel analysis of kidney biopsies obtained from CKD patients confirmed abnormal CYP24 expression in human disease as well.

16 Jun 2010

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

Hemispherx Biopharma, Inc., announced that the Company executed an exclusive revenue sharing Sales, Marketing, Distribution and Supply Agreement for Argentina with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA.

16 Jun 2010

UOHI tests Canada's first in-hospital program to screen and treat patients for diabetes

The University of Ottawa Heart Institute is testing Canada's first in-hospital program to screen and treat patients for diabetes, a growing epidemic in much of the Western world. The program is expected to lead to new ways to identify and cope with one of the most important risk factors for heart disease, particularly in women.

16 Jun 2010

HealthPrize Technologies takes fresh approach to prescription non-adherence problem

HealthPrize Technologies, a web-based software company that motivates people to fill and stay on their prescription medications, announced its official launch today. HealthPrize takes a fresh approach to the problem of medication non-adherence: it tracks users' medication taking and prescription refilling, educates consumers on the importance of taking medication properly, and rewards them for doing so.

15 Jun 2010

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Researchers reported today that Soliris® (eculizumab), a first-in-class terminal complement inhibitor developed by Alexion Pharmaceuticals, Inc., may provide clinical benefits to patients with thrombotic microangiopathy (TMA) resulting from uncontrolled complement activation. TMA, the formation of blood clots in capillaries and small arteries, can lead to life-threatening damage in multiple organs including kidney failure, thrombocytopenia (abnormally low platelet count) and anemia.

15 Jun 2010

Cardio-perfusion circuit patent portfolio offered for sale

ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a portfolio of three US issued patents relating to a condensed perfusion circuit for cardiac bypass. The technology of the portfolio should be of interest to any medical device company currently working in the cardiac surgery sector, or looking to establish a leading position in this growing field. This portfolio is a strong addition to ICAP Ocean Tomo's growing Bio/Life Sciences practice.

15 Jun 2010

Mechanical heart pumps can improve survival among patients with life-threatening heart failure: Thesis

Heart failure is a very common condition: around 200,000 people in Sweden have been diagnosed with the disease. Some patients with life-threatening heart failure can be helped by mechanical heart pumps, reveals a thesis from the University of Gothenburg, Sweden.

15 Jun 2010

Chronic News and Research

New book gives hope to women and families who are in difficult stages of anorexia treatment

VBL presents positive preclinical data on VB-201 for rheumatoid arthritis at EULAR

HGS, GSK announce full presentation of BLISS-76 Phase 3 BENLYSTA trial results for SLE at EULAR 2010

Deuterium depletion symposium focusses on oncotherapy, anticancer, diabetes, anti-aging research

HHS Secretary announces series of new investments to strengthen primary care workforce

Positive results from Cytomedix's AutoloGel System study for treatment of advanced, chronic wounds published

Hospital waiting time reduced nationally: Report

Wednesday's OpEds: Berwick nomination; Health reform costs and benefits; Medicaid and COBRA in jobs bill

Relypsa commences enrollment for RLY5016 Phase 2 study in heart failure patients with chronic kidney disease

Nuon Therapeutics NU1618 phase 2a study in hyperuricemia meets primary endpoint

Dutch researcher investigates causes and consequences of insomnia

CSMG, CSHA awarded Elite status

Interventions are needed to make people exercise after cardiac event

Newly published research examines association between CKD and CYP24

Hemispherx announces exclusive revenue sharing agreement with GP Pharm

UOHI tests Canada's first in-hospital program to screen and treat patients for diabetes

HealthPrize Technologies takes fresh approach to prescription non-adherence problem

Alexion's Soliris may benefit patients with thrombotic microangiopathy from uncontrolled complement activation

Cardio-perfusion circuit patent portfolio offered for sale

Mechanical heart pumps can improve survival among patients with life-threatening heart failure: Thesis

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News